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Laboratory strains of Mycosphaerella graminicola with decreased susceptibilities to the azole antifungal agent
cyproconazole showed a multidrug resistance phenotype by exhibiting cross-resistance to an unrelated chem-
ical, cycloheximide or rhodamine 6G, or both. Decreased azole susceptibility was found to be associated with
either decreased or increased levels of accumulation of cyproconazole. No specific relationship could be
observed between azole susceptibility and the expression of ATP-binding cassette (ABC) transporter genes
MgAtr1 to MgAtr5 and the sterol P450 14-demethylase gene, CYP51. ABC transporter MgAtr1 was identified
as a determinant in azole susceptibility since heterologous expression of the protein reduced the azole
susceptibility of Saccharomyces cerevisiae and disruption of MgAtr1 in one specific M. graminicola laboratory
strain with constitutive MgAtr1 overexpression restored the level of susceptibility to cyproconazole to wild-type
levels. However, the level of accumulation in the mutant with an MgAtr1 disruption did not revert to the
wild-type level. We propose that variations in azole susceptibility in laboratory strains of M. graminicola are
mediated by multiple mechanisms.
In wheat-growing areas Septoria tritici blotch, caused by the
fungus Mycosphaerella graminicola (anamorph, Septoria tritici),
is recognized as a major disease. The resulting loss in yield is
estimated to be millions of metric tons of grain and billions of
U.S. dollars each year (11). Therefore, control of this disease
either by resistance breeding or through chemical control is of
major importance.
An important group of antifungal agents used to control M.
graminicola is the sterol demethylation inhibitors (DMIs),
which interfere with ergosterol biosynthesis through inhibition
of the sterol P450 14-demethylase (P45014DM). Azole anti-
fungal agents in which the triazole ring acts as the active
moiety are the most important group of DMIs. They have
broad-spectrum antifungal activities, protective and curative
properties, and low levels of phytotoxicity. Although mutants
with resistance to DMIs could easily be obtained in the labo-
ratory, the risk of resistance development in the field was
initially considered low, as laboratory mutants generally suf-
fered a fitness penalty (10). At present, resistance to azoles is
widespread in various foliar pathogens, such as powdery mil-
dews and scab (18). However, these pathogens can still be
controlled by a limited number of DMIs with relatively high
levels of intrinsic activity. This is also true for the control of
septoria blotch of wheat, in which, despite the intensive use of
cyproconazole and other azole antifungal agents, no indica-
tions of decreased susceptibilities to these compounds have
been found (13).
Resistance to azole antifungal agents can be caused by al-
terations in sterol biosynthesis (20), mutations of the P45014DM
target site (19, 32), or increased levels of expression of the
P45014DM-encoding gene, CYP51 (15, 37). Another important
resistance mechanism is reduction of the intracellular concen-
tration of the antifungal agent by means of an increased active
efflux system. This mechanism operates in a broad variety of
both plant and animal pathogens and is attributed to the in-
creased activities of ATP-binding cassette (ABC) transporters
(2, 8, 9). ABC transporters became known for their role in
multidrug resistance (MDR) in human tumor cells (21). They
also function in MDR of filamentous fungi to antifungal agents
and unrelated chemicals (1, 3, 33).
We are interested in the role of ABC transporters from M.
graminicola in pathogenesis and in the susceptibility of this
fungus to antifungal agents. To assess the roles of these trans-
porters in the azole susceptibilities of M. graminicola, we se-
lected from two genetically independent strains laboratory
strains with decreased susceptibilities to the azole antifungal
agent cyproconazole. All strains were analyzed for their sus-
ceptibilities to azoles and other chemically unrelated com-
pounds, their levels of accumulation of [14C]cyproconazole,
and their levels of expression of five ABC transporter genes
(MgAtr1 to MgAtr5) and the sterol P450 14-demethylase gene
(CYP51). MgAtr1 was disrupted by Agrobacterium tumefaciens-
mediated transformation in strains with constitutive MgAtr1
overexpression, and the transformants were phenotypically
characterized. The results presented indicate that in M. gra-
minicola multiple mechanisms may contribute to the variations
in susceptibilities to azole antifungal agents.
MATERIALS AND METHODS
Fungal material and culture conditions. In this study two field isolates of M.
graminicola were used: isolate I323 was isolated in The Netherlands in 1981 (23),
and isolate M1 was collected in France in 1993 and was provided by J. M. Seng
(Biotransfer, Montreuil, France). Strains were grown yeast-like in liquid yeast-
sucrose medium (yeast extract, 10 g/liter; sucrose, 10 g/liter) at 18°C and 140 rpm
or on solid V8-agar plates (50% V8 vegetable juice, 50% water, 2.5% agar) at
18°C. The mycelium used in the accumulation studies was obtained by inoculat-
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ing 100 ml of Czapek Dox-mycological peptone (Czapek Dox medium, 33.4
g/liter; mycological peptone, 5 g/liter) with 3  104 cells per ml and incubation
on a rotary shaker (25°C, 140 rpm) for an additional 3 days.
Complementation of Saccharomyces cerevisiae was performed with strain
AD12345678 (yor1 snq2 pdr5 pdr10 pdr11 ycf1 pdr3 pdr15 ura3) (6).
Susceptibility assays and isolation of laboratory strains. The antifungal agents
tested were the triazoles cyproconazole (Syngenta, Basel, Switzerland), propi-
conazole (Syngenta), and tebuconazole (Bayer AG); the protein synthesis inhib-
itor cycloheximide (Sigma); and the dye rhodamine 6G (Sigma). The MICs for
yeast-like growing cells were determined on V8-agar plates or potato dextrose
agar plates (PDA; 39 g/liter). Toxicity tests were performed by spotting 5 l of
a suspension of cells (harvested from 3-day-old liquid medium with a density of
4  105 cells per ml) on 9-ml petri dishes containing V8-agar or PDA amended
with different concentrations of toxicants. The concentrations of the compounds
used in the susceptibility assays ranged from 0.025 to 1.5 mg/liter for the tria-
zoles, from 2.5 to 1,500 mg/liter for cycloheximide, and from 2.5 to 250 mg/liter
for rhodamine 6G. Experiments were performed three times in triplicate, and
MICs were assessed visually after 10 days of incubation at 18°C in the dark.
M. graminicola strains with decreased susceptibilities to the azole antifungal
agent cyproconazole were isolated by plating 105 yeast-like cells on V8-agar in
14-cm petri dishes amended with cyproconazole at three times the MIC for the
wild-type parent strains. After 10 days of incubation colonies were isolated from
these plates.
Assays of the susceptibilities of S. cerevisiae were performed on solid synthetic
medium containing Bacto Yeast Nitrogen Base without amino acids (6.7 g/liter),
dropout mix (2 g/liter containing amino acids without uracil), galactose (20
g/liter), Noble agar (20 g/liter), and cycloheximide or cyproconazole at various
concentrations. Cycloheximide was used at 0.01, 0.05, 0.1, and 0.25 g/ml; cypro-
conazole was used at 0.003, 0.01, and 0.025 g/ml; and rhodamine 6G was used
at 0.5, 1, and 5 g/ml. Cultures of S. cerevisiae were grown overnight in liquid
synthetic medium at 30°C. The overnight culture was diluted to an optical density
at 600 nm of 0.5, and subsequently, 5 or 10 l was spotted onto the plates. Drug
susceptibility was scored visually after incubation for 3 days at 30°C in the dark.
Gene disruption. A. tumefaciens-mediated transformation was used to disrupt
MgAtr1 in laboratory-generated strains I323C1 and M1C4. Generation of dis-
ruption constructs and selection of transformants with the disrupted MgAtr1 gene
were performed as described previously (42).
Accumulation of [14C]cyproconazole. Mycelium was homogenized and har-
vested by filtering over 0.85-mm- and 55-m-pore-size filters. Subsequently,
mycelium was washed with 50 mM sodium phosphate buffer (pH 6.0), resus-
pended in 50 mM sodium phosphate buffer (pH 6.0; 1% glucose) at a density of
6 mg (wet weight) per ml, and incubated for 30 min at 25°C and 140 rpm.
Subsequently, [14C]cyproconazole (kindly provided by Syngenta) was added to
an external concentration of 100 M. Mycelium (5 ml) was harvested at intervals
of 10 min by vacuum filtration and washed five times with 5 ml of phosphate
buffer, and the radioactivity in the biomass was measured with a Beckman
LS6000TA liquid scintillation counter. The level of accumulation of [14C]cypro-
conazole was calculated as the number of nanomoles per milligram (dry weight).
The energy dependency of [14C]cyproconazole accumulation was tested by the
addition of carbonyl cyanide 3-chlorophenylhydrazone (CCCP; 20 M) and
subsequent measurement of the level of [14C]cyproconazole accumulation.
DNA and RNA manipulations. M. graminicola genomic DNA isolated from
5-day-old yeast-like cells (29) was used to amplify the open reading frame of the
M. graminicola CYP51 gene (GenBank accession no. AF263470). Amplification
reaction volumes (50 l) contained dATP, dCTP, dGTP, and dTTP (200 M);
primers (1.2 M); AmpliTaq DNA polymerase (0.5 U; Perkin-Elmer); and a
reaction buffer (10 mM Tris-HCl [pH 8.3], 50 mM KCl, 3 mM MgCl2). DNA was
denatured for 3 min at 94°C, followed by 2 min at 50°C and 2 min at 72°C. This
initial cycle was followed by 29 cycles of 1 min at 94°C, 1 min at 58°C, and 1 min
at 72°C. The amplification was stopped with an extension of 10 min at 72°C. The
PCR primers used were CYP5 (GGTACCATGGGTCTCCTCCAGGAAG)
and CYP3 (TCCCTCCTCTCCCACTTTAC). The amplification products were
isolated from the agarose gel and directly sequenced.
Northern blot analysis was performed with RNA isolated from wild-type and
laboratory-generated strains. The levels of expression of ABC transporter-en-
coding genes MgAtr1 (GenBank accession no. AJ243112), MgAtr2 (GenBank
accession no. AJ243113) (41), MgAtr3 (GenBank accession no. AF364105),
MgAtr4 (GenBank accession no. AF329852), and MgAtr5 (GenBank accession
no. AF364104) (36) and the CYP51 gene were examined. Total RNA was iso-
lated by using the TRIzol reagent (Life Technologies). RNA (10 g) was sepa-
rated on a 1.2% agarose gel containing glyoxal and transferred to Hybond N
nylon membranes (Amersham). Equal loading and transfer of RNA were deter-
mined by staining Northern blots with methylene blue and hybridization with the
18S rRNA subunit of Aspergillus niger (26). Hybridizations were performed at
65°C in Nasmyth’s hybridization solution (1.1 M NaCl, 0.3 M Na2HPO4, 0.011 M
disodium EDTA, 1.85% sarcosyl, 18.5% dextran sulfate [pH 6.2], 100 g of
denatured herring sperm DNA per ml).
Complementation of S. cerevisiae. Full-length cDNA clones of MgAtr1 were
made from poly(A) RNA isolated from yeast-like cells of M. graminicola.
Amplification of full-length cDNA was performed with the Advantage Klentaq
polymerase mix (Clontech) according to the instructions of the manufacturer.
cDNA clones were cloned in the yeast expression vector pYes2 (Invitrogen) and
transformed into S. cerevisiae strain AD12345678. Yeast transformants contain-
ing the empty vector pYes2 were used as controls.
RESULTS
Assays of susceptibilities to azole antifungal agents. The
MICs of cyproconazole for field strains I323 and M1 were
approximately 0.1 g/ml on PDA and 0.3 g/ml on V8-agar.
Both strains showed similar cross-susceptibilities to the tria-
zoles propiconazole and tebuconazole (data not shown).
To elucidate the potential role of ABC transporters in sus-
ceptibility to azoles, strains I323 and M1 were subjected to
selection with cyproconazole. Strains with decreased suscepti-
bilities to cyproconazole were isolated from V8-agar plates
amended with cyproconazole at three times the MICs for both
parent strains. For both I323 and M1 the frequency of resistant
colonies was about 104. The relative decreases in the suscep-
tibilities of several strains were determined and ranged be-
tween factors of 3 and 6 (Table 1). All strains showed cross-
resistance to propiconazole and tebuconazole (data not
shown). Repetitive subculturing of the strains under nonselec-
tive conditions showed that all I323-derived strains were stable,
whereas M1-derived strains M1A1 and M1D1 lost their de-
creased susceptibilities to cyproconazole. The susceptibilities
of the strains to several chemically unrelated chemicals were
TABLE 1. Susceptibilities of field isolates, laboratory-generated
strains with decreased sensitivities to azoles, and MgAtr1 mutants of
M. graminicola with disrupted MgAtr1 to cyproconazole,
cycloheximide, and rhodamine 6G
Isolatea
MIC (g/ml)
Cyproconazole Cycloheximide Rhodamine 6G
I323 0.1 500 25
I323A1 0.4 1,000 25
I323C1 0.75 1,500 150
I323C4 0.5 1,000 25
I323E1 0.75 1,500 50
I323C11-1 0.1 25 25
I323C11-2 0.1 25 25
M1 0.1 500 15
M1A1 0.4b NDc 30
M1B1 0.3 ND 30
M1C1 0.3 ND 30
M1C4 0.5 1,500 100
M1D1 0.3b ND 30
M1C41-1 0.5 1,500 100
M1C41-2 0.5 1,500 100
a Strains I323A1, I323C1, I323C4, and I323E1 and strains M1A1, M1B1,
M1C1, M1C4, and M1D1 are laboratory-generated strains derived from wild-
type field isolates I323 and M1, respectively. Strains I323C11-1 and I323C11-2
and strains M1C41-1 and M1C41-2 are transformants of I323C1 and M1C4,
respectively, with a disrupted allele of MgAtr1.
b The strains were initially resistant; resistance was lost upon subculturing.
c ND, not determined.
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determined in order to study whether the strains had an MDR
phenotype. Indeed, all strains exhibited a low degree of cross-
resistance to cycloheximide and/or rhodamine 6G (Table 1).
Accumulation of [14C]cyproconazole. The decreased suscep-
tibilities of the strains to cyproconazole could be due to re-
duced levels of intracellular accumulation of the antifungal
agent in mycelial cells. Therefore, the levels of cyproconazole
that accumulated in cells were measured over time (Fig. 1A
and B). The levels of [14C]cyproconazole accumulation for the
two wild-type strains, strains I323 and M1, did not differ sig-
nificantly and amounted, on average, to 1 and 0.9 nmol of
cyproconazole per mg (dry weight), respectively. In all strains
derived from strain I323 the levels of accumulation of
[14C]cyproconazole decreased significantly by factors of 3 to 4
(Fig. 1A). The levels of accumulation by M1-derived strains
M1B1 and M1C1 decreased by factors of 2 to 3. In contrast, the
level of accumulation of [14C]cyproconazole by strain M1C4
was higher than the level of accumulation by the wild type and
increased over time (Fig. 1B). In all strains tested, the level of
accumulation appeared to be due to an energy-dependent ef-
flux, as the addition of CCCP increased the level of accumu-
lation of cyproconazole (Fig. 1C).
Northern analysis. The MDR phenotypes of the laboratory-
generated strains could indicate that ABC transporters are
involved in the mechanism of resistance (25). Therefore, the
levels of expression of ABC transporter-encoding genes
MgAtr1 to MgAtr5 were studied. Northern analysis with un-
treated yeast-like cells demonstrated that almost all laborato-
ry-generated strains exhibited changes in the basal level of
expression of at least one of the ABC transporter genes whose
levels of expression were tested (Fig. 2). For instance, the
levels of expression of MgAtr1 were highly increased in strains
I323C1 and M1C4 compared to those in their respective wild-
type parent strains. In addition, both strains showed increased
levels of expression of MgAtr5. Even strain M1A1, which lost
its resistance to cyproconazole, still showed a clear overexpres-
sion of an ABC transporter gene, e.g., MgAtr2. However, all
these expression data indicate that there is no consistent cor-
relation between the observed susceptibility profile of a strain
and the profile of expression of any of the ABC transporter
genes tested. All strains were also tested for levels of expres-
sion of the CYP51 gene. Only I323E1 showed, besides upregu-
lation of MgAtr4, an increased level of CYP51 expression.
Analysis of CYP51. Using primers directed against the
CYP51 gene from M. graminicola, a 1,903-bp fragment com-
prising the entire open reading frame was amplified from wild-
type strains I323 and M1 and from laboratory-generated
strains I323C1 and M1C4. The deduced amino acid sequences
of the proteins encoded by the genes from the wild-type strains
and both laboratory-generated strains were identical (data not
shown).
Analysis of MgAtr1. Strains I323C1 and M1C4 both con-
stitutively overexpressed MgAtr1 but showed opposite ac-
cumulation patterns. The role of MgAtr1 in the decreased
susceptibility to cyproconazole was analyzed in more detail by
complementation of an S. cerevisiae mutant with MgAtr1 and by
disruption of MgAtr1 in I323C1 and M1C4 by means of A.
tumefaciens-mediated transformation.
The heterologous expression of MgAtr1 in S. cerevisiae
showed that the presence of MgAtr1 results in the decreased
FIG. 1. (A) Levels of accumulation of [14C]cyproconazole in M.
graminicola wild-type isolate I323 (F) and laboratory-generated strains
with decreased cyproconazole susceptibilities, strains I323A1 (E),
I323C1 (Œ), I323C4 (‚), and I323E1 (). (B) Levels of accumulation
of [14C]cyproconazole in wild-type isolate M1 (F) and laboratory-gen-
erated strains M1A1 (E), M1B1 (Œ), M1C1 (‚), M1C4 (), and M1D1
(). (C) Relative increases in levels of accumulation of [14C]cypro-
conazole measured 30 min after addition of CCCP. DW, dry weight.
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susceptibilities of the yeast to both cycloheximide and cypro-
conazole (Fig. 3) Therefore, both cycloheximide and cyprocon-
azole are potential substrates of MgAtr1.
After A. tumefaciens-mediated transformation of both strain
I323C1 and strain M1C4, two disruptants each containing a
single copy of the transforming DNA were isolated and char-
acterized with respect to MgAtr1 expression, their azole sus-
ceptibilities, and levels of cyproconazole accumulation. North-
ern analysis demonstrated that disruption of MgAtr1 resulted
in the disappearance of full-length MgAtr1 mRNA (Fig. 4).
The levels of accumulation of [14C]cyproconazole by the
MgAtr1 disruptants of both I323C1 and M1C4 compared to
those for their respective parent strains were similar (data not
shown). The MgAtr1 disruptants derived from I323C1 had
wild-type (strain I323) susceptibilities to cyproconazole and
rhodamine 6G. Moreover, they became hypersensitive to cy-
cloheximide (Fig. 5A), demonstrating a role for MgAtr1 in
protection against these compounds in I323C1. In contrast, the
MgAtr1 disruptants derived from M1C4 remained less suscep-
tible to these compounds (Fig. 5B).
DISCUSSION
Laboratory-generated strains of M. graminicola with de-
creased susceptibilities to the azole antifungal agent cyprocon-
azole were selected at a rate of about 104. This frequency is
not unique for M. graminicola, since similar frequencies have
been observed for other filamentous fungi, e.g., Aspergillus
nidulans and Nectria haematococca. Genetic analyses of azole-
resistant strains of these organisms identified a polygenic sys-
tem for azole resistance (22, 38). Recently, in Candida glabrata
the development of so-called high-frequency azole resistance,
which occurred at frequencies (2  104 to 4  104) com-
parable to those in M. graminicola, was described (31). We
propose that the decreased susceptibilities of the laboratory-
generated strains can be regarded as microbial resistance (34)
The susceptibilities of the laboratory-generated strains are
still within the range observed in field populations of M. gra-
minicola (13). This suggests that the mechanisms underlying
the microbial resistance to azoles in laboratory strains can also
occur in natural populations of the pathogen and, thus, con-
tribute to the natural variation in baseline susceptibility.
Most strains of M. graminicola with decreased azole suscep-
tibilities exhibited cross-resistance to the chemically unrelated
compounds cycloheximide and rhodamine 6G. Such an MDR
phenotype in strains with decreased azole susceptibilities has
been described for the yeasts Candida albicans (33), C. glabrata
(31), and S. cerevisiae (4) and the filamentous fungi A. nidulans
(7), Botrytis cinerea (17), Penicillium digitatum (27), and Peni-
cillium italicum (14). Most laboratory strains of M. graminicola
FIG. 2. Expression of MgAtr1, MgAtr2, MgAtr4, MgAtr5, and CYP51
in M. graminicola wild-type strains (strains I323 and M1) and labora-
tory-generated strains (strains I323A1, I323C1, I323C4, I323E1,
M1A1, M1B1, M1C1, M1C4, and M1D1). The 18S rRNA gene was
used as a loading control.
FIG. 3. Effect of heterologous expression of MgAtr1 from M. gra-
minicola in S. cerevisiae AD12345678 on susceptibilities to cyclohexi-
mide, cyproconazole, and rhodamine 6G. Five or 10 l (rows 1 and 2,
respectively) of overnight cultures of two independent S. cerevisiae
transformants containing the full-length cDNA clone of MgAtr1 (A) or
control plasmid pYes2 (B) was diluted to an optical density at 600 nm
of 0.5 and spotted. The concentrations of compounds in the agar are
indicated in micrograms per milliliter.
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with an MDR phenotype exhibited decreased levels of accu-
mulation of cyproconazole. This observation suggests that the
MDR is associated with an energy-dependent transport of
drugs that results in a decreased cellular content of toxicants
(8, 9). However, the level of accumulation of [14C]cyprocon-
azole by strain M1C4 was higher than the level of accumulation
by the wild-type strain and increased over time. This indicates
that multiple mechanisms contribute to the variation in azole
susceptibility in M. graminicola. The increased level of accu-
mulation by M1C4 may be caused by cell wall changes that lead
to an increased level of nonspecific binding of the compound to
cell wall components. The relatively small increase in the level
of accumulation of [14C]cyproconazole in M1C4 after addition
of the uncoupler CCCP might offer support for this mecha-
nism. Increased levels of accumulation of azoles have also been
described for triadimenol-resistant laboratory strains of Usti-
lago maydis (40). An alternative mechanism for the increased
level of accumulation of cyproconazole by strain M1C4 might
be active sequestration of the fungicide in vacuoles. This pro-
tection mechanism is well described in plants, in which seques-
tration of endotoxins, heavy metals, and natural pigments oc-
curs through a specific subclass of ABC transporters (30).
In line with this explanation is the increase in the level of
[14C]cyproconazole accumulation in M1C4 over time.
Differences in levels of drug accumulation can be mediated
by changes in ABC transporter activity due to overexpression
of ABC transporter genes. Therefore, the levels of expression
of all ABC transporter genes cloned so far from M. graminicola
(MgAtr1 to MgAtr5) were analyzed in all strains. Northern
analysis indicated that the moderate changes in susceptibility
to azoles are associated with profound changes in the levels of
expression of the ABC transporter genes, suggesting that the
regulation of the genes examined in the laboratory-generated
strains is quite different from that in the parent strains. How-
ever, it is not possible to associate the level of expression of a
specific ABC transporter gene with the observed phenotype.
This indicates that multiple transporters may be involved in
azole susceptibility or that the transporter of prime importance
for azole transport in M. graminicola has not yet been identi-
fied.
We have studied the ABC transporter gene MgAtr1 in more
detail since this gene was overexpressed in strains I323C1 and
M1C4, which displayed decreased and increased levels of ac-
cumulation of cyproconazole, respectively. Complementation
of an S. cerevisiae mutant with MgAtr1 decreases the suscepti-
bilities of the yeast transformants to cyproconazole and cyclo-
heximide. Disruption of MgAtr1 in I323C1 restored the sus-
ceptibilities to cyproconazole and rhodamine 6G to wild-type
FIG. 4. Expression of MgAtr1 in M. graminicola wild-type strains
(strains I323 and M1), laboratory-generated strains (strains I323C1
and M1C4), and independent transformants of I323C1 and M1C4 with
a disrupted MgAtr1 allele (strains I323C1-1, I323C1-2, M1C4-1
and M1C4-2)
FIG. 5. Susceptibilities of M. graminicola wild-type strains, laboratory-generated azole-resistant strains, and MgAtr1 knockout mutants of
laboratory-generated azole-resistant strains to cyproconazole, cycloheximide, and rhodamine 6G. (A) Wild-type isolate I323 (quadrant 1),
laboratory-generated strain I323C1 (quadrant 2), and two independent transformants of I323C1 with the disrupted MgAtr1 allele (quadrants 3 and
4); (B) wild-type isolate M1 (quadrant 1), laboratory-generated strain M1C4 (quadrant 2), and two independent transformants of M1C4 with the
disrupted MgAtr1 allele (quadrants 3 and 4). The concentrations of cyproconazole (I), cycloheximide (II), and rhodamine 6G (III) used are
indicated in micrograms per milliliter.
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levels and even resulted in hypersusceptibility to cyclohexi-
mide. Therefore, all three compounds are potential substrates
of MgAtr1 in M. graminicola.
Disruption of MgAtr1 in I323C1 did not cause the level of
accumulation of cyproconazole to revert to the level found for
the wild-type strain. Thus, our data prove that MgAtr1 can
provide protection against azole antifungals in S. cerevisiae and
M. graminicola, but they also show that the overall level of
accumulation is not affected by the disruption of MgAtr1 in
strain I323C1. These seemingly conflicting results are hard to
explain but suggest that in I323C1 decreased influx and not
increased efflux by MgAtr1 causes the reduced level of accu-
mulation. Apparently, MgAtr1 can act as a determinant of
azole susceptibility only when it is overexpressed and when
azole influx is impaired. These results also imply that the over-
all level of accumulation of cyproconazole by laboratory
strains of M. graminicola is probably not an indicator of
either azole susceptibility or the exclusive involvement of
ABC transporters. This contrasts with the situation in A. nidu-
lans and B. cinerea (2, 35, 39) and emphasizes the complexity
of the mechanisms that contribute to azole accumulation in
M. graminicola.
As MgAtr1 was not upregulated in all laboratory strains
selected and as disruption of MgAtr1 in M1C4 did not alter the
phenotype, it is clear that besides overproduction of MgAtr1
other mechanisms act as determinants involved in the MDR
phenotype. Disruption of other ABC transporter genes in the
laboratory strains should indicate if additional ABC transport-
ers are involved. This is well possible, since ABC transporters
are members of a large protein superfamily and are known to
possess overlapping substrate specificities (5, 25).
Sequencing of CYP51 from M. graminicola strains I323C1
and M1C4 did not show any of the point mutations reported to
confer resistance to azole antifungal agents in C. albicans (12,
32). This indicates that, at least in these strains, mutations in
the CYP51 gene are not involved in decreased susceptibility to
cyproconazole. However, overexpression of CYP51, as ob-
served in strain I323E1, could contribute to decreased suscep-
tibility (15, 37).
In summary the data described here suggest that in labora-
tory strains of M. graminicola, multiple mechanisms contribute
to the variation in azole susceptibility. One mechanism in-
volves the upregulation of MgAtr1 and possibly more ABC
transporter genes, which lead to increased levels of efflux of
antifungal agents. Other mechanisms may involve changes in
cell wall composition or sequestration of the antifungal agent
in cellular compartments, resulting in increased levels of accu-
mulation. Finally, reduced levels of passive influx may play a
role. Multiple mechanisms probably operate in individual
strains. Multiple mechanisms of azole resistance also function
in C. albicans and P. digitatum (16, 24, 28). This situation
complicates investigations on mechanisms of resistance to
azoles in M. graminicola. At present, we are examining whether
multiple mechanisms also account for the variations in azole
susceptibility in field populations of M. graminicola.
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